Fang Jingyuan

[Expert Profile] Fang Jingyuan, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in gastroenterology in China, working in the Department of Gastroenterology, Renji Hospital, Shanghai Jiao Tong University School of Medicine. He has long been dedicated to clinical diagnosis, treatment, and scientific research of difficult gastrointestinal diseases, intestinal immune diseases, and gastrointestinal tumors, and is an important leading figure in gastroenterology in China.

[Education & Career] Professor Fang Jingyuan graduated from Shanghai Second Medical University (now Shanghai Jiao Tong University School of Medicine), completed systematic clinical training at Renji Hospital, and further studied at famous international gastroenterology centers. He has long served as Director of the Department of Gastroenterology at Renji Hospital, holding important academic positions including Vice Chair of the Gastroenterology Branch of the Chinese Medical Association. He has presided over key grants from the National Natural Science Foundation of China and the National Key R&D Program, and has achieved remarkable results in research on intestinal microecology and gastrointestinal diseases.

[Areas of Expertise] Professor Fang specializes in the diagnosis and treatment of difficult gastrointestinal diseases, inflammatory bowel disease, intestinal immune diseases, and early gastrointestinal tumors. He has extensive experience in assessing the association between gut microbiota and gastrointestinal diseases, endoscopic early cancer screening and minimally invasive endoscopic treatment, and comprehensive medical treatment of difficult gastrointestinal diseases. He excels at managing complex gastrointestinal cases of "abdominal pain, diarrhea, and gut microbiota dysbiosis," helping numerous patients receive clear diagnoses, standardized treatment, and prevention of gastrointestinal tumors.

[Academic Achievements & Industry Contributions] Professor Fang has led a series of translational studies on intestinal microecology and gastrointestinal diseases and tumors, systematically elucidating the mechanism of gut microbiota in the development and progression of colorectal cancer and other conditions, and exploring the application value of probiotics in tumor prevention and treatment. His findings have been published in top international journals, representing an important breakthrough in the field of intestinal microecology research. He has led the development of relevant Chinese digestive disease diagnosis and treatment guidelines and expert consensus statements, actively promoted the construction of early gastrointestinal cancer screening and standardized diagnosis and treatment systems, and made important contributions to the development of gastroenterology in China.

[Clinical Practice & Outstanding Contributions] Professor Fang has long held expert gastroenterology clinics, cumulatively treating tens of thousands of patients with various digestive diseases, and leading his team in conducting large-scale early gastrointestinal cancer screening, helping numerous patients achieve early diagnosis and early treatment. He has been repeatedly recognized as an outstanding discipline leader, trained a large number of gastroenterology professionals, and is deeply trusted by patients and respected by peers alike. He is an outstanding expert in the field of gastroenterology in China.

[Honors & Reputation] Professor Fang Jingyuan serves as Director of the Department of Gastroenterology at Renji Hospital, Shanghai Jiao Tong University School of Medicine and Vice Chair of the Gastroenterology Branch of the Chinese Medical Association, among other academic positions. He has presided over national-level projects including key grants from the National Natural Science Foundation of China and the National Key R&D Program, and is an authoritative expert in the field of gastroenterology in China. He has achieved remarkable results in research on intestinal microecology and gastrointestinal diseases and tumors, systematically elucidating the mechanism of gut microbiota in colorectal cancer and related conditions, with findings published in top international journals and receiving the National Science and Technology Progress Award. He has led the promotion of early gastrointestinal cancer screening and standardized diagnosis and treatment system construction, trained a large number of gastroenterology professionals, and is deeply trusted by patients and respected by peers alike.